Lack of significant genotoxicity of purified soy isoflavones – (03-31-03)

Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer.

This article is interesting given the fact that men with history of prostate cancer and women with history of breast cancer are told to avoid soy products. However, the evidence seems to support the fact that soy compounds are not only non-harmful, but possibly show a benefit.

AJCN — Abstracts: Miltyk et al. 77 (4): 875

Click here for more information.